Investors Overview
A $9.8B market still operating on 1970s-era workflows.
Microbiology testing is one of healthcare’s last un-digitized frontiers. Bioeureka’s AI is changing that — and the window to get in early is now.
$92B
Global market by 2030
8.5%
Annual market growth (CAGR)
4B+
Microbiology tests per year
$57
Average cost per test today
Market Segments
Three industries.
All urgent.
All underserved.
Food safety, healthcare diagnostics, and environmental testing each face regulatory pressure to test faster and more reliably — with no adequate AI solution on the market.
Food Safety Testing
$49B
Clinical Diagnostics
$31B
Environmental Testing
$12B
Competitive Advantage
No one else does this.
| Approach | Cost | Turnaround | AI Guided |
|---|---|---|---|
| Reference lab | $20–35 | 2–5 days | No |
| In-house manual | $15–25 | 24–48h | No |
| Bioeureka | $9–15 | 12–24h | Yes |
WHY INVEST
Early stage.
Multiple exit paths. Defensible IP.
Proprietary AI model trained on 100,000+ pathogen images — not replicable overnight
Hardware + software stack creates multi-point customer lock-in
SaaS recurring revenue from AIMO cloud platform with lab subscriptions
Strategic Acquisition
Prime M&A target for diagnostic majors (bioMérieux, Thermo Fisher, BD)
IPO Track
SaaS + hardware profile mirrors high-multiple MedTech listings
Licensing
AI model can be white-labeled to regional diagnostic networks
Pharma Partnerships
AMR research demand creates enterprise data licensing revenue
Ready to explore the opportunity?
See how Bioeureka’s technology works and what the growth roadmap looks like.
